These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 17478069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
    Di Cesare E, Cerone G, Enrici RM, Tombolini V, Anselmo P, Masciocchi C.
    Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
    [Abstract] [Full Text] [Related]

  • 3. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
    Stroszczynski C, Hosten N, Oellinger J, Spahn G, Amthauer H, Bittner RC, Hierholzer J, Ludwig WD, Felix R.
    Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O, Levis A, Garabello D, Foggetti MD, Depaoli L, Cirillo R, De Lucchi R, Orsucci L, Resegotti L.
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [Abstract] [Full Text] [Related]

  • 8. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L, Maffioli L, Bonfante V, Viviani S, Balzarini L, Gasparini M, Valagussa P, Bombardieri E, Santoro A, Bonadonna G.
    Ann Oncol; 1997 Mar; 8 Suppl 1():53-6. PubMed ID: 9187430
    [Abstract] [Full Text] [Related]

  • 9. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
    Balwierz W, Armata J, Moryl-Bujakowska A, Depowska T, Bogusławska-Jaworska J, Pisarek J, Sońta-Jakimczyk D, Janik-Moszant A, Rokicka-Milewska R, Sopyło B, Kołakowska-Mrozowska B, Radwańska U, Kołecki P, Kaczmarek-Kanold M, Kowalczyk J, Skomra S, Ochocka M, Matysiak M, Newecka-Samól T.
    Wiad Lek; 1998 Mar; 51 Suppl 4():12-7. PubMed ID: 10731938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
    Capua A, Osti MF, Scattoni Padovan F, Sarra R, Sbarbati S, Anselmo AP, Maurizi Enrici R.
    Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
    [Abstract] [Full Text] [Related]

  • 12. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E, Berardi F, Natalino F, Moleti ML, Di Rocco A, Enrici RM, Foà R, Martelli M.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1154-60. PubMed ID: 18472357
    [Abstract] [Full Text] [Related]

  • 13. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
    Advani R, Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ.
    J Clin Oncol; 2007 Sep 01; 25(25):3902-7. PubMed ID: 17664458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S, Petracchini M, D'Urso L, Dellamonica P, Illing R, Regge D, Muto G.
    BJU Int; 2008 Aug 01; 102(4):452-8. PubMed ID: 18476973
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance imaging of pelvic and femoral bones for detection of bone marrow infiltration in patients with non-Hodgkins lymphoma.
    Al-Mulhim FA.
    Saudi Med J; 2005 Jan 01; 26(1):31-6. PubMed ID: 15756349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
    Re A, Ferrari S, Frata P, Pizzocaro C, Crippa C, Tucci A, Facchetti F, Grazioli L, Magrini SM, Rossi G.
    Ann Oncol; 2008 May 01; 19(5):951-7. PubMed ID: 18209012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.